Manufacturer
DUOPHARMA (M) SDN. BHD.
Contents
cimetidine
Indication
Benign gastric and duodenal ulceration, Zollinger-Ellison syndrome
Instruction
Administer via IV.
Drug interaction
Reduces absorption of dasatinib, ketoconazole, itraconazole and posaconazole. May increase serum levels of phenytoin, theophylline, lidocaine, hydroxyzine and oral anticoagulants. Absorption may be reduced by antacids. Decreased bioavailability w/ metoclopramide, sucralfate or propantheline. May potentiate the myelosuppressive effects (e.g. agranulocytosis, neutropenia) of myelosuppressive drugs (e.g. antimetabolites, alkylating agents) or therapies (e.g. radiation).
Malaysia
